コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion of trigeminal inputs in diseases such as hemifacial spasm.
2 rs that affect one side of the face, such as hemifacial spasm.
3 nonsurgical treatment for blepharospasm and hemifacial spasm.
4 he eyelid for treatment of blepharospasm and hemifacial spasm.
5 t option for patients with blepharospasm and hemifacial spasm.
6 , 70.4 [9.1] years); of the 56 patients with hemifacial spasm, 25 (44.6%) used alleviating maneuvers
11 ients with benign essential blepharospasm or hemifacial spasm are known to use botulinum toxin inject
12 euvers for benign essential blepharospasm or hemifacial spasm correlates with disease severity or bot
13 viating maneuvers used for blepharospasm and hemifacial spasm, dystonia severity, and dose and freque
14 s [95% CI, -10 to 70 units]; P = .15) or the hemifacial spasm group (58 vs 60 units; Hodges-Lehmann m
16 nfants with similar semiology (described as "hemifacial spasm"), imaging findings, and histopathology
17 jection visits required by blepharospasm and hemifacial spasm patients during their course of treatme
18 iating maneuvers scored higher on the 7-item Hemifacial Spasm Quality of Life scale (median score, 7
20 ee disorders (strabismus, blepharospasm, and hemifacial spasm), the number of indications being treat
21 0 [95% CI, 0-1]; P = .03) than patients with hemifacial spasm who did not use alleviating maneuver.
23 essential blepharospasm and 56 patients with hemifacial spasm who were consecutively recruited from a
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。